Exane Derivatives Gilead Sciences, Inc. Transaction History

Exane Derivatives

$157 Million
Q2 2022

A detailed history of Exane Derivatives transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Exane Derivatives holds 13,537 shares of GILD stock, worth $1.25 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

13,537

Previous 18,384 26.37%

Holding current value

$1.25 Million

Previous $1.09 Million 23.44%

% of portfolio

0.53%

Previous 0.34%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $279,768 - $315,103	-4,847 Reduced 26.37%	13,537 $836,000
Q1 2022 Apr 22, 2022	BUY	$57.92 - $72.58 $210,597 - $263,900	3,636 Added 24.65%	18,384 $1.09 Million
Q4 2021 Jan 28, 2022	BUY	$64.88 - $73.64 $38,019 - $43,153	586 Added 4.14%	14,748 $1.07 Million
Q3 2021 Oct 26, 2021	BUY	$67.69 - $73.03 $644,476 - $695,318	9,521 Added 205.15%	14,162 $989,000
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $76,227 - $83,289	-1,201 Reduced 20.56%	4,641 $319,000
Q1 2021 Apr 30, 2021	BUY	$60.0 - $68.46 $29,580 - $33,750	493 Added 9.22%	5,842 $377,000
Q4 2020 Jan 27, 2021	SELL	$56.65 - $64.55 $883,286 - $1.01 Million	-15,592 Reduced 74.46%	5,349 $311,000
Q3 2020 Oct 06, 2020	SELL	$62.1 - $78.08 $738,990 - $929,152	-11,900 Reduced 36.24%	20,941 $1.32 Million
Q2 2020 Jul 10, 2020	BUY	$72.34 - $84.0 $1.89 Million - $2.19 Million	26,103 Added 387.4%	32,841 $2.53 Million
Q4 2019 Jan 22, 2020	SELL	$61.62 - $67.78 $3.25 Million - $3.57 Million	-52,721 Reduced 88.67%	6,738 $437,000
Q3 2019 Oct 15, 2019	SELL	$62.51 - $69.0 $34,818 - $38,433	-557 Reduced 0.93%	59,459 $3.77 Million
Q2 2019 Jul 12, 2019	SELL	$61.87 - $69.38 $379,634 - $425,715	-6,136 Reduced 9.28%	60,016 $0
Q1 2019 Apr 24, 2019	BUY	$62.53 - $70.05 $3.85 Million - $4.32 Million	61,625 Added 1361.28%	66,152 $0
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $717,911 - $875,212	-9,856 Reduced 68.53%	4,527 $0
Q4 2017 Jan 29, 2018	SELL	$71.15 - $83.52 $90,218 - $105,903	-1,268 Reduced 8.1%	14,383 $0
Q3 2017 Oct 18, 2017	BUY	$72.11 - $85.47 $1.13 Million - $1.34 Million	15,651	15,651 $0

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account

Exane Derivatives Gilead Sciences, Inc. Transaction History